Status:
RECRUITING
Bio-significance of LPC16:0 in Fibromyalgia
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Fibromyalgia, Primary
Pain
Eligibility:
All Genders
18-70 years
Brief Summary
Fibromyalgia (FM) is a very common but mysterious pain disorder characterized by chronic widespread muscular pain. Fatigue, anxiety and depression are common comorbidities. The syndrome is commonly as...
Eligibility Criteria
Inclusion
- 1\. Clinical diagnosis of fibromyalgia
Exclusion
- Systemic rheumatological or immune disorders (e.g., systemic lupus erythematosus, inflammatory myositis),
- Systemic use of corticosteroids,
- Pregnancy,
- Chronic diseases under poor control
- Malignancies.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT04832100
Start Date
June 1 2021
End Date
June 30 2027
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan, 80756